Written answers

Wednesday, 24 February 2021

Department of Health

Vaccination Programme

Photo of Michael MoynihanMichael Moynihan (Cork North West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

824. To ask the Minister for Health if there are plans in place to review the position of persons with cerebral palsy on the prioritisation list for Covid-19 vaccinations, with a view to ensuring they receive vaccinations earlier; and if he will make a statement on the matter. [9645/21]

Photo of Michael MoynihanMichael Moynihan (Cork North West, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

825. To ask the Minister for Health if there are plans in place to review the position of persons with muscular dystrophy on the prioritisation list for Covid-19 vaccinations, with a view to ensuring they receive vaccinations earlier; and if he will make a statement on the matter. [9646/21]

Photo of Donnchadh Ó LaoghaireDonnchadh Ó Laoghaire (Cork South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

861. To ask the Minister for Health the position of persons with Addison’s disease on the Covid-19 vaccination schedule; and when persons with the condition can expect to receive the vaccine. [9820/21]

Photo of Donnchadh Ó LaoghaireDonnchadh Ó Laoghaire (Cork South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

890. To ask the Minister for Health if his attention has been drawn to the disproportionate mortality rates from Covid-19 among kidney patients, which is similar to that of residents of long-term care facilities; if the vaccination allocation sequencing has been reviewed with this in mind; if he has engaged with advocates of kidney patients such as an association (details supplied) or with the HSE national renal office on the matter; and if he will make a statement on the matter. [9882/21]

Photo of Donnchadh Ó LaoghaireDonnchadh Ó Laoghaire (Cork South Central, Sinn Fein)
Link to this: Individually | In context | Oireachtas source

891. To ask the Minister for Health if those at high risk due to liver transplants will be prioritised for receipt of the Covid-19 vaccine; and when they can expect to receive the vaccine. [9883/21]

Photo of Holly CairnsHolly Cairns (Cork South West, Social Democrats)
Link to this: Individually | In context | Oireachtas source

916. To ask the Minister for Health if persons with chronic kidney disease will be given the same priority allocation as nursing home residents in the Covid-19 provisional vaccination priority list, given that they are in a vulnerable high-risk group; and if he will make a statement on the matter. [9961/21]

Photo of Neasa HouriganNeasa Hourigan (Dublin Central, Green Party)
Link to this: Individually | In context | Oireachtas source

918. To ask the Minister for Health if he will consider prioritising persons with cystic fibrosis on the vaccine priority list. [9981/21]

Photo of Alan KellyAlan Kelly (Tipperary, Labour)
Link to this: Individually | In context | Oireachtas source

924. To ask the Minister for Health when kidney patients are due to be vaccinated against Covid-19; if he will consider examining their place on the prioritisation list; and if he will make a statement on the matter. [10011/21]

Photo of Fergus O'DowdFergus O'Dowd (Louth, Fine Gael)
Link to this: Individually | In context | Oireachtas source

983. To ask the Minister for Health if matters raised in correspondence by a person (details supplied) in respect of kidney patients and their position in the Covid-19 vaccine roll-out will receive a response; and if he will make a statement on the matter. [10178/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 824, 825, 861, 890, 891, 916, 918, 924 and 983 together.

The COVID-19 Vaccine Allocation Strategy sets out a provisional list of groups for vaccination. The Strategy was developed by the National Immunisation Advisory Committee (NIAC) and my Department, endorsed by the National Public Health Emergency Team (NPHET), and approved by Government on 8 December 2020.

Vaccine allocation is a matter for my Department and further information is available here: .

The rollout of the COVID-19 vaccination programme is the responsibility of the HSE.

The aim of the COVID-19 vaccination programme is to ensure, over time, that vaccine will become available to vaccinate all of those for whom the vaccine is indicated. Given that there will be initially limited vaccines available, it will take some time for all to receive those vaccines and that has necessitated an allocation strategy to ensure that those most at risk of death and serious illness receive the vaccine first.

The priority is to first vaccinate and protect directly the most vulnerable amongst us, that is, those most likely to have a poor outcome if they contract the virus. The priority is to directly use vaccines to save lives and reduce serious illness, hence the focus on the over 65 year old cohort in long term residential care facilities, and healthcare workers in frontline services often caring for the most vulnerable.

The next group to be vaccinated are those aged 70 and older in the following order: 85 and older, 80-84, 75-79, and 70-74. Vaccination of this group began in February.

On the 23rdof February, I announced an update to Ireland’s COVID-19 Vaccine Allocation Strategy.

In comprising the initial Vaccine Allocation Strategy, the NIAC listed several conditions associated with increased risk of severe disease and death. In the intervening period, national and international evidence has become available which has enabled a more detailed analysis of underlying conditions that may increase the risk of developing severe disease or death.

The NIAC has now been able to more comprehensively identify those medical conditions and to distinguish between those which place a person at very high or high risk of severe disease if they contract the virus. Medical conditions and the magnitude of the risk they pose will continue to be monitored and periodically reviewed.

The NIAC continues to monitor data around this disease and indeed emerging data on effectiveness of vaccines on a rolling basis.

Further details are available at the following link:

Photo of Fergus O'DowdFergus O'Dowd (Louth, Fine Gael)
Link to this: Individually | In context | Oireachtas source

826. To ask the Minister for Health the number of nursing home residents who have now received their second Covid-19 vaccination; if there are nursing home residents who wish to be vaccinated but have not yet been able to receive the first vaccination; and if he will make a statement on the matter. [9649/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.

Photo of Joan CollinsJoan Collins (Dublin South Central, Independents 4 Change)
Link to this: Individually | In context | Oireachtas source

828. To ask the Minister for Health if meetings have been initiated with the UK Government to access surplus vaccines it has pre-ordered; and if he will make a statement on the matter. [9654/21]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Ireland is participating in a Procurement Exercise being operated by the European Commission on behalf of Member States to procure suitable, safe and effective vaccines, in sufficient quantities, to combat COVID-19. Six APAs have been negotiated by the Commission under this process to date.

Ireland has opted-in to five APAs to secure vaccine supplies: BioNTech/Pfizer, Moderna, AstraZeneca, Janssen/J&J and CureVac. Government approval has been obtained to opt-into the sixth APA (GSK/Sanofi Pasteur), subject to the outcome of clinical trial results.

Ireland has signalled its solidarity with the EU approach and has, through its participation, gained access to a broad range of vaccines that it might not otherwise have access to, and at the cost agreed collectively by the EU.

Comments

No comments

Log in or join to post a public comment.